Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

Market open

/zigman2/quotes/205619834/composite

$

344.71

Change

-1.03 -0.30%

Volume

Volume 537,914

Oct 27, 2021, 9:55 a.m.

Real time quotes

/zigman2/quotes/205619834/composite

Previous close

$ 345.74

$ 344.71

Change

-1.03 -0.30%

Day low

Day high

$343.11

$350.64

Open
Open: 344.25

52 week low

52 week high

$65.49

$497.49

Open

Market cap

$141.10B

Average volume

13.00M

P/E ratio

43.56

Rev. per Employee

$617,996

EPS

8.01

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrna

MarketWatch News on MRNA

  1. Novavax is seeking authorization in the U.K. for its COVID-19 vaccine

    8:47 a.m. Today

    - Jaimy Lee

  2. FDA advisors recommend BioNTech and Pfizer’s COVID-19 shot for children

    8:19 a.m. Today

    - Jaimy Lee

  3. This Little Company Thinks It Can Beat Long Covid

    7:47 p.m. Oct. 26, 2021

    - Bill Alpert

  4. Moderna Inc. stock falls Tuesday, underperforms market

    4:31 p.m. Oct. 26, 2021

    - MarketWatch Automation

  5. This Biotech Stock Could Rebound Nicely

    11:22 a.m. Oct. 26, 2021

    - Josh Nathan-Kazis

  6. FDA Advisors Discuss Covid Vaccines for Children Today

    12:01 a.m. Oct. 26, 2021

    - Josh Nathan-Kazis

  7. Moderna Inc. stock outperforms market on strong trading day

    4:31 p.m. Oct. 25, 2021

    - MarketWatch Automation

  8. Moderna Announces Positive Data on Covid-19 Vaccine in Children

    10:17 a.m. Oct. 25, 2021

    - Josh Nathan-Kazis

  9. Moderna plans to submit data to US FDA, EMA and other regulatory agencies

    8:36 a.m. Oct. 25, 2021

    - Ciara Linnane

  10. Moderna says Phase 2/3 study of CoVID vaccine in kids aged 6 to 11 showed 'robust' antibody response after 2 50 mg doses

    8:36 a.m. Oct. 25, 2021

    - Ciara Linnane

  11. Moderna Inc. stock falls Friday, underperforms market

    4:31 p.m. Oct. 22, 2021

    - MarketWatch Automation

  12. Loading more headlines...
/news/nonmarketwatch/company/us/mrna

Other News on MRNA

  1. What's Going On With Novavax Stock?

    6:55 a.m. Today

    - Motley Fool

  2. Should You Invest in the iShares Biotechnology ETF (IBB)?

    6:20 a.m. Today

    - Zacks.com

  3. Novavax: Excellent Vaccine, Questionable Management

    7:09 p.m. Oct. 26, 2021

    - Seeking Alpha

  4. Moderna Covid-19 Vaccine Data Shows Strong Response in Children

    10:24 a.m. Oct. 26, 2021

    - Peter Loftus

  5. Swissmedic approves booster shot of Moderna's COVID-19 vaccine

    9:54 a.m. Oct. 26, 2021

    - Seeking Alpha

  6. Wall Street Breakfast: Wild $T1mes!

    6:53 a.m. Oct. 26, 2021

    - Seeking Alpha

  7. Was Atea Pharmaceutical's Flop Predictable?

    6:45 a.m. Oct. 26, 2021

    - Motley Fool

  8. Why Moderna Stock Surged Today

    7:22 p.m. Oct. 25, 2021

    - Motley Fool

  9. U.S. to Exempt Certain Foreign Air Travelers From Vaccine Rules

    2:55 p.m. Oct. 25, 2021

    - Stephanie Armour

  10. A Look at the Role Luck Can Play in Investing

    1:39 p.m. Oct. 25, 2021

    - GuruFocus.com

  11. Loading more headlines...
/news/pressrelease/company/us/mrna

Press Releases on MRNA

  1. When the Price of Moderna Inc. Common Stock MRNA Talks, People Listen

    10:03 p.m. Oct. 25, 2021

    - Stock Traders Daily

  2. FDA Approves COVID-19 Booster Shots From Moderna And J&J

    7:27 a.m. Oct. 21, 2021

    - Baystreet.ca

  3. When the Price of Moderna Inc. Common Stock MRNA Talks, People Listen

    12:03 a.m. Oct. 16, 2021

    - Stock Traders Daily

  4. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.